Zynex's turnaround is nearing an end as UnitedHealthcare's new policy cuts its payments by 80% - equivalent to 40-100% of 2021 EBITDA. We recommend initiating short positions.

The devices are similar to transcutaneous electrical nerve stimulation, or TENS, units — small, battery-powered devices used for pain relief — but Zynex incorporates modalities found in ...

Zynex Inc. management let the medical device company overbill insurers to juice up revenue, prompting its largest insurance customer to pause payments while it scrutinized past claims, and causing a ...

In the second quarter, Zynex grew revenue by 11% to $49.9 million with earnings per share (EPS) of $0.04, which was actually down 55% from the $0.09 print in the year-ago quarter.

Zynex has completed the clinical verification trial of its pulse oximeter, NiCO, marking a significant milestone towards the Food and Drug Administration (FDA) clearance. Overseen by Duke ...

According to Zynex, the reduction in workforce was part of a planned adjustment in its order processing and billing strategy, and is unrelated to the Tricare temporary payment suspension.

Zynex, Inc. (NASDAQ:ZYXI) just released its latest full-year report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

What happenedShares of Zynex (NASDAQ: ZYXI) are up more than 9% early Wednesday afternoon after the medical equipment company announced it planned to do a stock repurchase. That said, the stock is ...

Zynex (ZYXI) announced highlights from a recent study comparing its NiCO laser pulse oximeter to conventional LED pulse oximeters for the effects of skin pigmentation on SpO2 measurements. Zynex ...

Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical ...